[1]Han SJ, Zhang SW, Cjhen WQ, et al. Analysis of prevalence and epidemic trend of bladder cancer in China[J]. Cancer Progression, 2013, 11(1):89-95. (in Chinese)
韩苏军, 张思维, 陈万青,等. 中国膀胱癌发病现状及流行趋势分析[J]. 癌症进展, 2013, 11(1):89-95.
[2]Valverde R, Edwards L, Regan L. Structure and function of KH domains[J]. Febs Journal, 2008, 275(11):2712-2726.
[3]El-Naggar M, Ebbing E, Bijnsdorp I, et al. Radiosensitization by thymidine phosphorylase inhibitor in thymidine phosphorylase negative and overexpressing bladder cancer cell lines[J]. Nucleosides Nucleotides & Nucleic Acids, 2014, 33(4-6):413-421.
[4]Allchorne P, Lamb BW, Kinsella J, et al. Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure[J]. Urologic Nursing, 2014, 34(2):95-99.
[5]Buchetpoyau K, Courchet J, Le HH, et al. Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies.[J]. Nucleic Acids Research, 2007, 35(4):1289-1300.
[6]Draper BW, Mello CC, Bowerman B, et al. MEX-3 is a KH domain protein that regulates blastomere identity in early C elegans embryos[J]. Cell, 1996, 87(2):205-216.
[7]Cano F, Bye H, Duncan LM, et al. The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation[J]. EMBO J, 2012, 31(17):3596-3606.
[8]Sheth U, Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies[J]. Science, 2003, 300(5620):805-808.
[9]Teixeira D, Sheth U, Valenciasanchez MA, et al. Processing bodies require RNA for assembly and contain nontranslating mRNAs.[J]. Rna-a Publication of the Rna Society, 2005, 11(4):371-382.
[10]Jiang H, Zhang X, Luo J, et al. Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells.[J]. Mol Medi Rep, 2012, 6(3):575-580.
[11]Pereira B, Sousa S, Barros R, et al. CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness.[J]. Nucleic Acids Res, 2013, 41(7):3986-3999.
[12]Krepischi ACV, Maschietto M, Ferreira EN, et al. Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors[J]. Mol Cytogenet, 2016, 9(1): 20.
|